QUIZ 2 LEC Investigational Drugs and Drug Approval Process

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/109

flashcard set

Earn XP

Description and Tags

Comprehensive practice flashcards covering drug laws, IND requirements, clinical trial phases, ethical frameworks, pharmacy roles, and case studies based on PHA6123.

110 Terms

1
New cards

Which act provided for the inspection and detention of imported drug shipments that failed to meet prescribed standards?

Import Drug Act of 1848

2
New cards

Which legislation required that drugs must not be mislabeled or adulterated?

Pure Food and Drugs Act of 1906

3
New cards

How did the Food, Drug, and Cosmetic Act of 1938 require the safety of drugs to be proven?

Through testing before marketing

4
New cards

Which amendment divided pharmaceuticals into over-the-counter (OTC) and prescription (Rx) classes?

Durham-Humphrey Amendment of 1951

5
New cards

What did the Kefauver-Harris Drug Amendment of 1962 mandate manufacturers demonstrate prior to marketing?

Proof of efficacy as well as safety

6
New cards

What is the FDA review target timeline for standard drugs?

10 months10\text{ months}

7
New cards

What is the FDA review target timeline for priority drugs?

6 months6\text{ months}

8
New cards

Which web-based system developed by the NIH provides information on ongoing clinical trials?

ClinicalTrials.gov

9
New cards

What is the main goal of the International Conference on Harmonisation (ICH)?

To provide a method to ensure simultaneous submission and rapid regulatory approval worldwide

10
New cards

Which historical code established that the voluntary consent of the human subject is absolutely essential?

Nuremberg Code

11
New cards

Which document re-emphasized the protection of human subjects and specified that subjects must be free from coercion?

Declaration of Helsinki (1964)

12
New cards

What was delineated in the Belmont Report of 1978?

The basic ethical principles underlying medical research on human subjects

13
New cards

What was the former name of the Food and Drug Administration (FDA) in the Philippines mentioned in the text?

Bureau of Food and Drugs (BFAD)

14
New cards

Which test subjects are primarily used during pre-clinical tests in drug discovery and development?

Animals

15
New cards

Who files a Commercial Investigational New Drug (IND) application with the FDA?

A corporate entity sponsor

16
New cards

Who is responsible for filing an Investigator IND?

An individual researcher

17
New cards

Which FDA form serves as the Cover Sheet for an Investigational New Drug (IND) application?

Form 1571

18
New cards

Which section of an IND application describes the rationale, indications, and types of trials to be conducted?

Introductory statement and general investigational plan

19
New cards

Which document provides investigators with all available information on a drug, including formula, pharmacokinetics, and safety?

Investigator's Brochure

20
New cards

What does the patient selection section in an IND clinical protocol describe?

Characteristics of eligible patients and exclusion factors

21
New cards

Which IND data section focuses on synthesis, preparation, and analytical methods to ensure purity and stability?

Chemistry, manufacturing, and control data

22
New cards

Although the FDA does not require placebos to be identical to the investigational drug, what must the lack of similarity not do?

Jeopardize the trial

23
New cards

Which IND submission is used to report a serious and unexpected suspected adverse reaction?

IND safety report

24
New cards

Within how many calendar days must a sponsor report a serious and unexpected suspected adverse reaction in writing to the FDA?

15 calendar days15\text{ calendar days}

25
New cards

Within how many days of the annual effective date must IND annual reports be submitted to the FDA?

60 days60\text{ days}

26
New cards

Which clinical trial phase involves the first administration of an investigational drug in humans?

Phase I

27
New cards

How many subjects are typically enrolled in a Phase I clinical trial?

20 to 80 subjects20\text{ to }80\text{ subjects}

28
New cards

What is the primary objective of a Phase II clinical trial?

Evaluate the efficacy of the agent in patients with the condition

29
New cards

How many patients are typically treated in a Phase III clinical trial?

Several hundred to 3,000 patients3,000\text{ patients}

30
New cards

Which clinical trial phase is considered pivotal and serves as the primary basis for a New Drug Application (NDA)?

Phase III

31
New cards

What term defines the study of variations of DNA and RNA characteristics related to drug response?

Pharmacogenomics

32
New cards

Which expedited review process is used for drugs treating unmet medical needs by increasing communication with developers?

Fast Track Review

33
New cards

Which expedited FDA program allows approval based on a surrogate endpoint reasonably likely to predict clinical benefit?

Accelerated Approval

34
New cards

For what patient population does Expanded Access permit the clinical use of investigational drugs outside a clinical trial?

Patients with serious or life-threatening diseases

35
New cards

Under Expanded Access, what are manufacturers permitted to charge for an investigational new drug?

Recovery costs attributable to making the IND

36
New cards

What are post-marketing clinical studies initiated after a drug is approved called?

Phase IV

37
New cards

What does the FDA regulatory acronym REMS stand for?

Risk Evaluation and Mitigation Strategies

38
New cards

What does the acronym ETASU stand for within a REMS program?

Elements to Assure Safe Use

39
New cards

An orphan drug treats a rare disease affecting fewer than how many people in the United States?

Fewer than 200,000 people200,000\text{ people}

40
New cards

What period of marketing exclusivity is granted to the first sponsor of an approved orphan drug?

7 years7\text{ years}

41
New cards

What is the mandatory membership affiliation requirement for at least one member of an Institutional Review Board (IRB)?

Must not be affiliated with the institution

42
New cards

Who acts as the official liaison between the Institutional Review Board (IRB) and the study sponsor?

The principal investigator (PI)

43
New cards

What requirement must clinical research protocols satisfy regarding patient risk?

Risks must be minimal and the risk/benefit ratio reasonable

44
New cards

Which specific actions constitute research misconduct in clinical studies?

Fabrication, falsification, or plagiarism

45
New cards

What preparation guidelines should a pharmacist verify are included in an investigational drug protocol?

Stability and compatibility information

46
New cards

What consideration can pharmacists evaluate during an economic review to help manage drug costs?

Whether the therapy can be converted from inpatient to outpatient

47
New cards

Which specific identifier must be documented on investigational drug accountability records?

Lot number of the drug

48
New cards

What is a study called when neither the clinical researchers nor the data analysts know which drug was administered?

Triple Blinded

49
New cards

Which recurring fee charged by an investigational pharmacy covers standard drug storage and inventory?

Monthly fee

50
New cards

What fee does an investigational pharmacy charge when services exceed the standard services included in the base fee?

Professional fee

51
New cards

What was the main function of the Import Drug Act of 1848?

Provided for inspection of imported drug shipments

52
New cards

What did the Pure Food and Drugs Act of 1906 require regarding drugs?

Required drugs not be mislabeled or adulterated

53
New cards

What did the Food, Drug, and Cosmetic Act (FD&C Act) of 1938 require prior to marketing?

Required safety to be proven before marketing

54
New cards

How did the Durham-Humphrey Amendment of 1951 divide pharmaceuticals?

Divided pharmaceuticals into OTC and Rx

55
New cards

What did the Kefauver-Harris Amendment of 1962 mandate before drug marketing?

Specified proof of efficacy and safety prior to marketing

56
New cards

What foundational principle was set forth by the Nuremberg Code?

Stated voluntary consent is absolutely essential

57
New cards

What core subject protection was emphasized in the Declaration of Helsinki?

Re-emphasized protection; subjects must be free from coercion

58
New cards

What was the primary contribution of the Belmont Report?

Delineated basic ethical principles for human research

59
New cards

What was the purpose of CFR Title 45 Part 46?

Designed to make protection of human subjects uniform in federal agencies

60
New cards

What does the International Council for Harmonisation (ICH) ensure for drug development globally?

Ensures simultaneous submission and rapid regulatory approval globally

61
New cards

What is FDA Form 1571 in an IND submission?

Cover sheet identifying the sponsor and CRO

62
New cards

What is contained within an Investigator's Brochure?

Contains all info on drug formula, pharmacokinetics, and safety

63
New cards

What does the Introductory Statement of an IND describe?

Describes the rationale, indications, and types of trials

64
New cards

What is projected in the General Investigational Plan of an IND?

Projects the number of patients and general approach

65
New cards

What components are detailed in an IND Clinical Protocol?

Details objectives, patient selection, and dosing

66
New cards

What does the Chemistry Data section of an IND outline?

Describes synthesis, preparation, and analytical methods

67
New cards

What data is presented in the Previous Human Experience section of an IND?

Summarizes data from US and foreign markets regarding safety

68
New cards

What is the purpose of an IND Protocol Amendment?

Used to amend study design or protocol details

69
New cards

What is an IND Safety Report, and what is its submission timeframe for serious adverse reactions?

Must be submitted within 15 days15\text{ days} for serious adverse reactions

70
New cards

When must an IND Annual Report be submitted?

Submitted within 60 days60\text{ days} of the effective date to show progress

71
New cards

What defines a Phase I clinical trial?

Uses normal healthy volunteers to determine safety

72
New cards

What defines a Phase II clinical trial?

Evaluates efficacy in a small number of patients with the disease

73
New cards

What defines a Phase III clinical trial?

Treats hundreds to 3,000 patients3,000\text{ patients} in multicenter studies

74
New cards

What defines a Phase IV clinical trial?

Post-marketing studies after drug approval

75
New cards

What is the target review timeframe for FDA Priority Review?

FDA sets target to review the drug in 6 months6\text{ months}

76
New cards

What criteria form the basis for Accelerated Approval?

Based on a surrogate endpoint likely to predict clinical benefit

77
New cards

Which investigational drugs are eligible for Breakthrough Therapy designation?

For drugs showing substantial improvement over available therapy

78
New cards

What is the purpose of Risk Evaluation and Mitigation Strategies (REMS)?

Safety measures required beyond labeling to outweigh risks

79
New cards

What is an investigational pharmacy Base Fee?

Pharmacy charge that is fixed based on patient population or complexity

80
New cards

What defines Double Blinding in clinical study methodology?

Neither the patient nor the researchers know the drug assignment

81
New cards

True or False: In drug discovery, the test subjects used in pre-clinical tests are usually human volunteers.

False (Pre-clinical testing uses animals or in-vitro laboratory tests, not humans)

82
New cards

True or False: An investigator IND is filed by a corporate pharmaceutical entity.

False (An investigator IND is filed by an individual researcher; a commercial IND is filed by a corporate entity)

83
New cards

True or False: The average time for a drug to go from initial synthesis to NDA approval is approximately 15 years.

True (It takes an average of approximately 15 years15\text{ years} from initial synthesis to NDA approval)

84
New cards

True or False: Phase III clinical trials are typically multicenter studies.

True (Phase III trials are multicenter studies treating several hundred to 3,000 patients3,000\text{ patients})

85
New cards

True or False: ClinicalTrials.gov is a web-based system developed by the FDA.

False (It was developed by the National Institutes of Health [NIH], not the FDA)

86
New cards

True or False: The Belmont Report was established to judge the human experimentation conducted by Nazis.

False (The Nuremberg Code was used to judge Nazi experimentation; the Belmont Report delineated basic ethical principles)

87
New cards

True or False: An IND is always required, even if the drug is already marketed and being studied for its approved indication without increasing patient risk.

False (An IND is not required if the studied drug is marketed in the US and meets specific exemption requirements)

88
New cards

True or False: Under Expanded Access, the FDA allows manufacturers to charge for the drug to secure a large profit.

False (Sponsors can only charge recovery costs attributable to making the IND, not for profit)

89
New cards

True or False: Expanded access to investigational drugs is permitted for any minor condition.

False (It is only allowed for serious or immediately life-threatening diseases where no comparable therapy exists)

90
New cards

True or False: Pharmacogenomics studies the impact of a certain genotype or phenotype on drug response and adverse events.

True (Pharmacogenomics is defined as the study of DNA/RNA variations related to drug response)

91
New cards

True or False: An Orphan Drug is one used for the treatment of a disease affecting more than 500,000 people.

False (An orphan drug is for a rare disease affecting fewer than 200,000 people200,000\text{ people} in the US)

92
New cards

True or False: The Orphan Drug Act directly speeds up the FDA's clinical trial approval timeline.

False (It provides incentives like tax breaks and 7 years7\text{ years} of marketing exclusivity, but does not alter the approval timeline)

93
New cards

True or False: An Institutional Review Board (IRB) must include at least one individual who is not affiliated with the institution.

True (The IRB must have at least one individual not affiliated with the research institution)

94
New cards

True or False: The Principal Investigator has no direct interaction with the human subjects in a trial.

False (The investigator has direct communication with the human subjects, whereas the sponsor usually does not)

95
New cards

True or False: Informed consent in a clinical trial may be solely verbal and undocumented.

False (Informed consent must be documented in writing)

96
New cards

True or False: Research misconduct includes fabrication, falsification, or plagiarism in proposing or performing research.

True (Fabrication, falsification, or plagiarism constitutes research misconduct)

97
New cards

True or False: A pharmacy's Professional Fee is charged for drug storage and inventory.

False (A Monthly Fee covers drug storage and inventory; a Professional Fee is for services that exceed standard services)

98
New cards

True or False: Drug accountability records must be retained at the study site for 2 years after NDA approval or study discontinuation.

True (Records must be maintained for 2 years2\text{ years} after approval or FDA notification of discontinuation)

99
New cards

True or False: In a single-blinded study, the researchers do not know what drug is given, but the patient does.

False (In a single-blinded study, the patients do not know what they are given, but the researchers do)

100
New cards

True or False: REMS must be assessed for adequacy at least by 18 months, 3 years, and 7 years after approval.

True (The text specifies REMS assessments at 18 months18\text{ months}, 3 years3\text{ years}, and 7 years7\text{ years})